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A study was undertaken to determine the prevalence of virus infection in 
lambs undergoing respiratory tract disease (RTD). The investigation was divided 
into three study groups and consisted of lambs which were 4 to 5 months of age. 
In the first group (N=200), paired serum samples were taken from lambs (on entry 
into the feedlot and 21 days later).  In addition, lambs in the group which died of 
RTD were necropsied and tissue was cultured for the presence of bacteria and ex­
amined for viral antigen by fluorescence microscopy, (respiratory syncytial virus, 
RSV; parainfluenza-3  virus,  PI-3; border disease  virus, BDV; and ovine 
adenovirus-6, OVA-6). During the 21 day test period, 47 lambs died of RTD but 
only 40 were available for study. Antigen to RSV was detected most frequently 
(37.5% of cases).  This was followed by PI-3 (23%), OVA-6 (15%) and BDV 
(7.5%).  More than one virus was detected in 20% of cases.  Ten different 
bacteria were isolated from lung tissue.  There were not enough isolations of 
bacteria to statistically associate a specific type of bacteria with any of the viruses. 
Paired serum samples from surviving lambs (N=153) were examined for serocon­
version to the viruses tested above plus blue tongue virus (BTV). Seroconversion 
to PI-3 was most commonly observed (47% of cases). This was followed by RSV 
(35%), OVA-6 (16%), BDV (5%) and BTV (2%). The second Oregon study involved a seroprevalence from a representative 
number of lambs (N=50) from five different pens in the feedlot at the same time as 
the first study (each pen contained 200 lambs).  Serum samples were taken as 
lambs entered the feedlot and a second sample (N=50) was taken from lambs from 
same group 24 days later. A significant increase (P=.001 to .05) in the percentage 
of lambs possessing antibodies to the test viruses was detected in all cases. The 
most dramatic change occured with RSV (36% to 88% prevalence) and OVA-6 
(48% to 86% prevalence). Changes in percentage of lambs with antibodies to P1-3 
and BDV were less dramatic. 
The third study was undertaken in a Colorado feedlot. Serum samples were 
taken as lambs entered the facility (N=200) and a second (paired) serum sample 
was taken 21 days later from the same lambs. Nineteen lambs died of RTD but 
they were not examined for presence of viral antigen. Seroconversion in surviving 
lambs was highest with P1-3 (51%). This was followed by OVA-6 (19%), RSV 
(17%) and BTV (1%). VIRUSES ASSOCIATED WITH RESPIRATORY
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I. INTRODUCTION 
Diseases affecting the respiratory system of sheep and goats are relatively 
common. It is probably accurate to state that respiratory disease contributes more 
to morbidity and mortality among young small ruminants than does any other in­
fectious disease. 
Most authorities agree that the etiology of respiratory disease in ruminants is 
multifactorial and among those the virus involvement is a major primary cause. 
The viruses that appear to have the greatest potential to predispose lambs to respi­
ratory diseases includes adenovirus, parainfluenza-3, border disease virus and re­
spiratory syncytial virus.  All of these viruses usually cause mild respiratory 
disease with fever, anorexia, sporadic coughing, pneumonia and listlessness.' 
Respiratory disease is not limited to USA but is a worldwide problem. The 
author is a citizen of Pakistan and when he returns to his country he will be in-
charge of developing biologics for prevention of diseases in sheep and goats. 
Livestock production is the principal occupation of the inhabitants of Balochistan 
(PAKISTAN). About 80% of the people depend directly or indirectly on livestock 
rearing. Sheep and goats are the major livestock species of the province. There 
are 11.1 million sheep and 7.4 million goats in the province which constitutes 40% 
and 23% of total country's sheep and goats respectively. 
Overall productivity of these animals is low due to poor feeding, management 
and prevalence of various viral, bacterial and parasitic diseases.  These animals 2 
acquire 90% of their feed requirements from grazing on rangeland where the for­
age availability is very low. This, in turn, predisposes the animals to various in­
fectious diseases. 
The economic effects of respiratory diseases in sheep and goats include mor­
talities as well as indirect estimators of morbidity such as increased time to reach 
market weight, poor feed conversion, higher rates of culling, poor carcass com­
position, increased condemnation at slaughter and extra cost and time for medica­
tion and veterinary services.' 
The present investigation was designed to study the viral causes of respiratory 
diseases in sheep in two feedlots in the United States. Using the information and 
diagnostic skills in the current study as a model, the author plans to establish diag­
nostic and research projects in his native country in order to control some of the 
respiratory problems in sheep and goats. 3 
II. LITERATURE REVIEW
Respiratory tract disease in sheep is a complex syndrome caused by a num­
ber of infectious microorganisms plus the interaction of environment, nutritional, 
and other poorly defined factors.'" In attempting to determine the role of viruses 
in this disease, serologic prevalence as well as virus isolation studies are of value. 
Using these methodologies, individual viruses as well as groups of viruses which 
naturally infect an animal can be determined. Subsequently, more detailed inves­
tigations can then be undertaken to define the significance of each virus which has 
been shown to infect the specie in question. These more detailed studies may in­
volve serologic response to a virus taken at specific times to determine sequence of 
infection. This is then correlated with appearance of naturally occurring disease. 
Additional studies may also involve attempts to reproduce the disease by exper­
imental inoculation of a virus into a group of animals and to determine the patho­
genesis of infection. 
A comprehensive literature review of all viral agents which may cause respi­
ratory tract disease in the sheep would be an overwhelming task and beyond the 
scope of this study. Accordingly, a general summary of the importance of some of 
the viruses will be presented i.e., bovine viral diarrhea (BVD)/border disease virus 
(BDV), pararinfluenza-3 virus (PI-3), blue tongue virus (BTV) and respiratory 
syncytial virus (RSV).  Diagnostic procedures and reagents are well defined for 
these viruses as are the availability of commercial vaccines. The importance of 
these viruses in respiratory tract diseases of sheep has not been clearly defmed but 
it is generally assumed they have a causal relationship. To be contrasted with 
above mentioned viruses, adenoviruses present another situation. Diagnostic pro­
cedures are not well defmed nor are the different antigenic strains of viruses gener­
ally available to researchers in the USA. Vaccines are not available for sheep 4 
adenoviruses in the USA. Accordingly, a more extensive literature review will be 
presented for adenoviruses in order to obtain a more complete understanding of 
these agents in the ovine respiratory disease complex. 
Historical Background 
The discovery of influenza virus in 1933,5 greatly enhanced the search for 
additional agents which induced respiratory diseases in humans. Respiratory dis­
eases continued to impose substantial clinical and economical problems; disease 
was referred both in terms of endemic and epizootic episodes.5 The search re­
mained generally unsuccessful until Enders et al. developed tissue culture produc­
tion methods which allowed the efficient in vitro cultivation of viruses.' Shortly 
here after, two research groups described the isolation and characterization of 
adenoviruses. First, Rowe and coworkers detected adenoviruses in explants of in­
fected human adenoid tissue."' Secondly, Hilleman and Werner, studying an epi­
demic of influenza disease in army recruits, isolated several similar cytopathogenic 
agents from respiratory secretions added to cultures of human upper respiratory 
tissues.5 As the virus was detected from the adenoid tissue, the name adenoviruses 
was retained in classifying these agents.' Following the isolation of human adeno­
viruses, veterinary virologists began the search for adenoviruses which infect ani­
mals.  These viruses have now been detected from a wide range of animal 
species." 
Host Range 
Adenoviruses are ubiquitous58 and the number of species isolated and charac­
terized is increasing with the passage of time. Animals for which adenoviruses are 
described includes cattle,  horses,  sheep,  goat,  llamas, pigs,  birds, mice and 
reptiles.11,65,87,95  For the time being there are 9 bovine ,21 6 ovine, 118  2 caprine,89 
4 porcine, 1 equine, 1 murine, and 14 avian 93 species of adenoviruses.  Many 5 
other have been isolated but have not yet officially classified. Adenovirus infec­
tions are primarily host specific; however, cross infections can occur among close­
ly related species. For example, lambs can be infected by bovine adenoviruses.128 
Pathogenicity of Human Adenoviruses 
There are now 41 distinct antigenic types of human adenoviruses.' Infection 
has been associated with a wide variety of disease syndromes, including conjuncti­
vitis, pharyngitis, keratitis, bronchitis, bronchiolitis with pneumonia, cystitis and 
enteritis. 
28, 62, 101, 121  Infection is usually mild but is much more severe in children 
and military recruits.' Likewise, different adenovirus types vary in their virulence 
with some strains more consistently inducing severe disease.' 
Bovine Adenoviruses 
Klein and coworkers first reported' the presence of an adenovirus in cattle in 
the USA. They isolated bovine adenovirus (BA) from the feces of an apparently 
healthy cow.' Subsequently, numerous other investigators reported the isolation 
of these agents from a variety of disease syndromes.  Bovine adenoviruses are 
unique in that there appears to be two diverse virus types which infect this species. 
Accordingly, BA are classified into two subgroups.  Subgroup one BA (species 
1,2,3,and 9) possess common group-specific complement-fixating antigens with 
adenoviruses of all mammalian types, as well as other unique features, i.e., types 
of inclusion body, etc. Subgroup two BA (species 4-8) do not possess group-
reactive antigens but show other unique functions.  In addition, the two different 
subgroups of BA appear to vary in regard to their pathogenesis of infection and 
manner by which virus can be detected in infected animals." 
Bovine adenoviruses have been isolated from apparently normal animals and 
those exhibiting a variety of disease syndromes. Some members of BA subgroup 
one have been associated with enteritis and pneumonia.  Subgroup two BA 6 
frequently induce a viremia with viral localization in the respiratory and enteric 
tracts and corresponding signs of disease being expressed as pneumonia and 
enteritis!'  " Likewise, viremia allows access to the developing fetus and results 
either in fetal death or neonatal infection. 4, 30, 36, 42, 120 
Ovine Adenovi ruses 
Currently, six antigenic species of ovine adenoviruses (OAV) and two spe­
cies of caprine adenoviruses (CAV) have been described.89 These numbers will 
unquestionably increase as research continues. 
Ovine adenovirus (OAV) have been isolated from numerous countries. The 
percentage of adult animals possessing antibodies to these agents (indicating pre­
vious infection) varies from 60 to near 100 percent.14, 17, 18, 37, 92, 116 Ovine adenovi­
ruses are frequently isolated from clinically normal lambs as well as from lambs 
with a history of enteric and respiratory disease. Further studies have shown these 
viruses to be etiologic agents of lamb pneumonia and diarrhea. Lambs experimen­
tally infected with OAV show signs of pyrexia, anorexia, hyperpnea, dyspnea, 
conjunctivitis, cough, and diarrhea.' Like BA, some species of OAV have been 
shown to produce a viremia in the dam resulting in fetal disease.' 
It is now apparent that interspecies transmission of BAV, OAV and CAV can 
occur and sheep have been shown on several occasions to be naturally infected 
with viruses previously classified as BAV.18 It is also apparent that young animals 
appear to express signs of disease more consistently when infected with adenovi­
ruses than do older animals. Likewise, sheep experimentally infected with OAV 
followed by bacterial pathogens develop more severe signs of disease and patho­
logic changes than when infected with either microorganism individually." 7 
Isolation and Serological Studies (OAV) 
Successful attempts to isolate adenovirus from sheep were made as early as 
1969 by Mc Ferran et al. in Ireland.' On the basis of morphology,  physical and 
serological properties,  adenoviruses which were isolated from the feces of dis­
eased sheep, suggested their possible role in producing pneumoenteritis in sheep. 
Bela reported that change in sheep production practices i.e., from smaller 
units to larger production units, resulted in populations of inhomogeneous immu­
nological history in which the spread of known and unknown infectious disease 
has been promoted by lack of protection in part of the animals.' Nasal discharge 
and fecal examination of lambs during an outbreak showed the  presence of reovi­
ruses, PI-3 virus, and adenoviruses. Further studies indicated that the major part 
of economic losses were due to adenoviruses which accounted for 30-40-% 
mortality in suckling and 10-15% in fattening lambs. 
Bel& and Palfi described the involvement of adenovirus in an epidemic 
among fattend lambs showing clinical signs of pneumoenteritis.' Later, Bel& et 
al.  described the epizootology of a respiratory syndrome in lambs and suggested 
an adenovirus initiated disease!' The virus, OAV strain Het13, was recovered from 
the nasal secretions of affected lambs." The virus was later shown to be related 
antigenically to BAV type 2. When lambs were kept in close units, they had less 
natural resistance because a large number of animals  are gathered from different 
sources with different degrees of immunity. Under these conditions, along with 
poor ventilation, respiratory and enteric diseases developed in sheep in a fattening 
facility. This research group also described the course of disease by observing that 
the ailment started with pyrexia and diarrhea. Two to three days following the di­
arrhea, signs of respiratory involvement appeared.  Conjunctivitis, sneezing, 
coughing and nasal discharge were the commonly observed signs.  Diarrhea per­
sisted for only 7 days but the respiratory symptoms remained for another week. 8 
As time progressed, the nasal discharge became seropurulent, marked cough and 
other respiratory disorders developed, all of which indicated signs of chronic in­
fection. As is common with most viral infections, bacterial involvement was also 
apparent.  Secondary infection was characterized by high fever, loss of appetite 
and forced respiration. The disease in suckling lambs resulted in heavy losses." 
An epizootological study of respiratory tract diseases and isolation/identifica­
tion of OAV 5 and 6 was done in newly weaned lambs.' Lambs were housed in 
an isolated barn with semiconfinement conditions. Over an eight-week period of 
study, lambs developed respiratory disease syndrome and were separated from the 
sheep not showing the signs of disease.  The morbidity rate amounted to 13% 
whereas the total mortality was 4.1%, of which 57.6% was due to pneumonia. 
Adenovirus was present in 36% of lung specimens with pneumonia. Virus neutral­
ization test indicated the presence of OAV-5 and OAV-6, showing that more than 
one OAV serotype was present within the same flock at the time. 
Dubey and Sharma reported the presence of OAV-1 in India which was iso­
lated from the showing signs of pneumoenteritis. Nasal and fecal samples were in­
oculated in embryonic lamb kidney (LK) cells in order to isolate the virus. He 
subsequently conducted a seroprevalence survey for antibodies to OAV-1 in an In­
dian province. Survey showed that 4.05% (44/1086) sheep, 9.15% (26/284) goats, 
16.03% (21/131) water buffaloes and 4.68% (21/448) cattle had precipitating 
antibodies."'''" 
In a further study, Duby and Sharma showed that Sheep and goats of semi­
arid Rajahistan a region of India, had antibodies against OAV-1 antigen. Agar gel 
precipitation test (AGPT) showed that 8.62% (54/625) of sheep and 6.45% (4/62) 
of goats had antibodies against OAV-1.  The research group observed a marked 
difference among exotic breeds 50% (23/46), higher crosses 33.33% (12/36) and 
half bred 4.79% (18/474) animals while native animals did  not showed the 9 
prevalence of antibodies to this virus.'  In further studies, a local isolate of 
OAV-1, isolated from sheep showing signs of pneumoenteritis, was propagated in 
different cell cultures of sheep and goat origin. All the cell cultures supported the 
growth of the virus but there were some differences in CPE and virus yield. Lung 
cell cultures showed a later CPE than kidney and testicular cultures, whereas the 
kidney cell cultures yielded higher titers than did testicular and lung cell cultures.' 
Using lamb kidney cultures, Mc Ferran and coworkers' isolated three  sero­
logically distinct OAV from feces of sheep. Two of these three isolated strains 
showed cross reactivity to adenovirus group antigens. Their work suggested that 
adenoviruses can be recovered from both healthy and diseased animals. Detection 
of OAV from the feces suggested their involvement in enteric infections. Darby­
shire and Pereira (1964) suggested, on the basis of gel precipitation test (a group 
specific test), that sheep are naturally infected with adenoviruses.' But apart from 
a preliminary report ( Mc Ferran et al.  1969) there was no previous report of isola­
tion of sheep adenoviruses." 
Davies and Humphreys' described the characterization of two strains of ade­
novirus which were recovered from sheep in New Zealand over a period of 10 
months. Samples were collected from nasal secretions, feces and lungs of dead 
animals and propagated in lambs testicular (LT) cultures. Two distinctly different 
adenovirus species were isolated, neither of which agglutinated  mouse, rat, guinea 
pig ,  sheep, cattle, or human '0' erythrocytes, but one of the isolates agglutinated 
chicken erythrocytes. Both strains were serologically distinct on the basis of cross 
neutralization test.  However, their relationship to five established serotypes of 
ovine adenovirus was not determined. 
Sharp and colleagues described a new adenovirus in sheep."' They showed 
that this new strain,  7769, was quite distinct from the three serotypes of OAV pre­
viously isolated.  They were able to demonstrate that strain  7769 was not 10 
neutralized by antisera to BAV as were the three serotypes isolated earlier. They 
inoculated the virus in pathogen-free lambs. It replicated and stimulated an immu­
nological response without producing any clinical signs. This suggested that either 
strain 7769 was non-pathogenic or cause disease in conjunction with other agents 
or factors. 
Sharp and Rae "'conducted a serosurvey in Scotland to determine the pres­
ence of antibodies to ovine adenovirus species 1 to 4. They obtained serum sam­
ples from 600 healthy lambs (25 farms) with the objective of demonstrating both 
SN (type-specific) and precipitating antibodies (group specific) antigen. Approxi­
mately 6% of the serum showed precipitation antibodies by gel diffusion tests, but 
neutralizing antibodies against all OAV species were present at much higher 
prevalence i.e., 83%. 
Rushton and Sharp"' reported that antibodies to ovine adenovirus type 4 
were present in as high as 70% of serum of sheep of all ages in Britain.  Virus 
was recovered from 8 to 10 weeks old lambs showing the signs of pneumonia. 
Adenovirus group specific antigens were detected in sheep and goats by Der­
byshire in United Kingdom.' Serum from different animals, including sheep and 
goats, was tested in parallel with a human adenovirus type 5 by using the AGID 
test. Results showed that 1/103 sheep and 33/50 goats had precipitating antibodies 
against adenovirus group antigen. 
Thurley and colleaguest' described the causes of sub-clinical pneumonia in 
New Zealand lambs.  According to their findings, besides bacterial, serum anti­
body titres to two adenoviruses were found. Two serological distinct viruses (later 
confirmed as OAV) were isolated from feces and nasal secretions of sheep. 
Two previous isolates of OVA from lambs in the central USA, designated as 
RTS-42 and RTS-151, were classified by Adair and colleagues.  Two-way cross 11 
neutralization test with six recognized OAV species, nine BAV species and four 
porcine adenovirus species was performed with these two isolates. Isolate RTS-42 
was identified as OAV type 5 and virus RTS-151 as OAV type 6.1 
Two serotypes of adenoviruses were isolated from sheep in Central America. 
Lehmkuhl and Cut lip" characterized these isolates and found that isolate RTS-42 
was neutralized by antiserum to ovine adenovirus (OAV) serotype 5 while another 
isolate, RTS-151, could not be neutralized by any of the antisera to OAV sero­
types 1-5 or bovine adenovirus (BAV) 1-8.  However, RTS-151 did contain the 
adenovirus group specific antigen as demonstrated by agar gel precipitation test. 
Both isolates were propagated in ovine fetal cornea (OFC) cells and all showed the 
typical adenovirus CPE. Further, agar gel immunodiffusion tests showed that a 
common antigen was shared between BAV-3 and the RTS-42 and RTS-151 iso­
lates of OAV. Erythrocytes from different species were not agglutinated by either 
of the viruses isolated." 
In a seroprevalence and microbiological study for pneumonia in New Zea­
land lambs, beside describing bacterial isolation and lesions, Pfeffer et al. reported 
the isolation of adenoviruses which were neutralized by antiserum to a local un­
typed strain of OAV (WV 757/75).1' 
Gibbs and coworkers' reported the presence of adenoviruses in goats in Ni­
geria. While examining the mucosal scraping from the large intestine of two goats 
for the presence of morbillivirus, an adenovirus was present in each sample in 
addition to the morbillivirus. The isolates replicated in primary lamb kidney cell 
culture with typical adenovirus cytopathogenic effects.  The isolates were con­
firmed to be adenovirus by electron microscopy. When the isolates  were com­
pared antigenically with recognized adenoviruses for possible cross-reactivity, 
neither of them could be typed as one of the nine bovine and five ovine adenovi­
ruses.  Using one way neutralization test, one isolate cross reacted with ovine 12 
adenovirus type 2, 3 and 5 and bovine adenovirus 1, 2, and 3, while the other was 
related to ovine adenovirus type 2. On this basis, both isolates were considered to 
be different serotypes. When compared by the group specific gel precipitation 
test, these investigators were able to demonstrate the presence of the group-
specific antigen. A serologic survey showed that 35 out of 36 (97%) goats and 23 
out of 28 (82%) sheep had antibodies to the respective viruses. 
An Australian group, Peet et al., described the presence of adenovirus in the 
liver of sheep which died due to cycad poisoning.2 Cross neutralization test was 
carried out with this isolate, designated as PI1537/82, with the eight species of 
BAV, six species of OAV and four species of porcine adenovirus. The PI1537/82 
was only neutralized by antiserum to a New Zealand adenovirus type (WV 757) 
and BAV-7 and was not neutralized by other adenovirus antiserum tested.  Also, 
antiserum against PI1537/82 virus neutralized the WV 757 and BAV-7. Adenovi­
rus group -specific antigen for PI1537/82 isolate was demonstrated by cross immu­
nofluorescence between PI1537/82 and OAV-4 and also confirmed by the 
reciprocal of this test  i.e., OAV-4 infected cells were stained by PI1537/82 
antiserum.2 
Occurrence of natural in utere adenoviral infection in sheep was studied by 
using three adenovirus strains isolated from the kidney of 174 sheep fetuses. 
These  isolates were related antigenically to BAV-2.  Neutralizing antibodies 
against BAV-2 were present in 20% (5/25) blood samples of sheep fetuses. This 
study proved that transplacental transfer of adenovirus infection is possible 
naturally. 
Tury and coworkers' isolated an adenovirus strain (Het/3) from nasal dis­
charge of lambs with respiratory disease. The isolate later was shown to be related 
antigenically to BA-2. 13 
Experimental Studies (OAV) 
To confirm that the Het \3 adenovirus strain was the etiological agent of the 
disease, Bel& and coworkers inoculated 1 week old colostrum-deprived lambs 
with the virus." The Het\3 adenovirus strain was propagated in fetal lamb kidney 
cultures and inoculated intratracheally and intranasally on alternate days. In addi­
tion to experimental infected sheep, some lambs were kept as contact controls. All 
inoculated and contact animals showed the signs of respiratory disease including 
cough, elevated body temperature, pneumonia and diarrhea. Virus was reisolated 
from the respiratory and intestinal tracts, as well as from the nasal and rectal 
swabs.' In the same study Bela and coworkers, 1975, showed that serum viral 
neutralization (SN) antibody titers varied from 1:8 to 1:128 in recovered sheep. 
These investigators concluded that virus (strain Het/3) was an important etiologic 
agent for ovine pneumonia and diarrhea.' 
Experimental infection in young lambs was produced with an isolate of 
OAV-1 isolated in India.' Virus was reisolated from the nasal and rectal swabs 
between 3-9 days PI. No virus was recovered from any other organ or body fluid. 
Serum antibody appeared on day 7 PI and reached maximum on day 13 PI. Fluo­
rescent antibody test (FAT) showed viral presence in epithelium of respiratory 
tract, endothelial cells of capillaries and reticulum cells of intestine. 
Sharp and coworkers infected two week old lambs with strain 7769 of OAV 
type 4.115 Virus was recovered from both nasal and rectal swabs for up to 9 days 
after exposure. Lambs developed a SN antibody titre increase which confirmed 
the fact that they became infected but failed to develop clinical signs of disease. 
While this study showed that the virus replicated in both the enteric and respirato­
ry tracts, it was flawed in that the lambs possessed low levels of SN antibodies 
prior to infection which probably prevented expression of disease. 14 
Palya and coworkers inoculated 3-week-old colostrum-deprived lambs with 
OAV type 1 strain GY/14.1" The agent had previously been recovered from a 
natural outbreak of respiratory tract disease in lambs. The virus was inoculated by 
intranasal and intratracheal routes.  It was recovered from nasal secretions and 
feces for up to 10 days post inoculation (PI). Lambs developed moderate signs of 
disease attributed to the alimentary and respiratory tracts. The investigators com­
pared pathologic changes observed in lambs experimentally infected with strain 
GY/14 and Het/3. They concluded that GY/14 appeared to induce more severe 
pathologic changes.'" 
In further studies with OAV strain GY/14, Palfi and coworkers" noted that 
the acute phase of infection was manifested by signs of respiratory disease with as­
sociated pathologic changes. In the chronic phase of disease, signs were limited to 
reduced growth rate, varying degrees of anorexia and intermittent pyrexia. Patho­
logic changes were observed in the lungs and kidneys. Virus isolation was diffi­
cult in the chronic phase of the disease as the organ involved, e.g lung explants, 
had to be cultured with ovine fetal cells.  Lambs produced a good antibody re­
sponse to the virus with the titre  varying from 1:32 to 1:128 on day 17 post in­
oculation.  The authors concluded that some lambs shed virus for prolonged 
periods of time for factors not completely understood." 
Lelunlcuhl and Cutlip experimentally' reproduced disease in one week old, 
colostrum-deprived lambs infected with RTS-151. Trachea and nasal routes were 
used for inoculation. A mild clinical response was observed between day 4-10 PI 
with peak clinical signs on day 7 PI. Lambs were necropsied on different days but 
virus was not recovered from the tissue homogenates of intestine, feces, liver or 
kidney. However, nasal secretions collected in between 2-8 days PI showed the 
virus. Preinoculation serums were negative to RTS-151 antibodies but antibodies 
first appeared on day 6 PI with detectable levels on day 8 PI. The titers were > 15 
256 from day 8 to 21 PI.  Failure to reisolate the virus after 8 day of inoculation 
was due to appearance of virus neutralizing antibodies in the serum. Antiserum to 
RTS-151 was prepared in sheep and labeled with fluorescein.  Lung sections, 
when stained with labeled antibody, showed the presence of antigen while the an­
tigen was absent in sections of liver, kidney, and small intestine. This observation 
was unique because in previous studies using other isolates, workers were able to 
demonstrate virus in digestive and urinary tracts in addition to the respiratory tract. 
The authors concluded that adenovirus strain RTS-151 may represent a new strain 
of adenovirus both in its antigenic character and organs it infects, although the le­
sions it produced were similar to those as of OAV-6. The study also indicated that 
OAV strain RTS-151 is pathogenic to young lambs. In a follow up of the pre­
vious study" Cut lip and Lehmkuhl described the lesions of the disease which  gen­
erally consisted ofconsolidation of lungs in lambs killed sequentially to day 21 PI. 
One week old, colostrum deprived lambs were infected with strain RTS-42 
(Mastadenovirus Ovi 5) and sacrificed on different days after inoculation until 21 
days PI.' Virus was present in nasal secretions and lung tissues in all sheep killed 
between 1-6 day PI. The investigators were not able to recover the virus from any 
other organ including intestine.  Virus neutralization antibodies first appeared on 
day 6 PI and were high in the serum of lambs killed on day 12 PI, but the titers had 
dropped in serums collected on day 21 PI.  Because virus was not isolated from 
any organ except the lungs, the author suggested that RTS-42 is a respiratory virus. 
The presence of virus in feces can be explained by observation that RTS-42 is acid 
resistant and may have replicated in respiratory tract and passed through the di­
gestive tract. 
Lehmkuhl et al. experimentally inoculated' 10-20-days old lambs with 
OAV-6 or Pasteurella haemolytica (Ph) or OAV-6 followed by Ph 6 days PI. The 
group which received OAV-6 or Ph alone developed mild clinical disease after 6 16 
and 3 days PI, respectively. Animals which were inoculated first with virus and 
then with bacteria, developed clinical signs of respiratory disease of greater inten­
sity and longer duration. This observation confirmed the concept of viral/bacterial 
synergism in producing severe disease in animals.  This concept suggests that 
pneumonia initiated by virus provides an environment for bacteria to localize and 
proliferate in lungs whereas bacteria alone are removed efficiently from the lungs 
by body defensive mechanisms. Virus neutralizing antibodies were detected in se­
rum on day 6 PI and levels increased to day 15 PI. Virus was present in nasal mu­
cosa, tracheal fluid and lung tissues between 2-8 days PI. 
New Zealand investigators Davies and Humphreys experimentally infected 3 
to 4 months old colostrum-deprived lambs with an untyped OAV isolate strain 
757/15. The virus, which was administered intranasally and intratracheally, in­
duced moderate clinical signs of respiratory tract disease.  Pathological changes 
were limited to the respiratory tract. The lambs experienced a viremia as the virus 
was detected for up to 14 days after infection in blood.' 
Davies and coworkers experimentally infected lambs with an untyped OAV 
isolate, strain WV 419/75 which was recovered from the feces of a healthy lamb.' 
The virus induced clinical signs of disease.  Virus was reisolated from nasal 
secretions and irregularly recovered from the small intestine, kidney and lymphoid 
tissue. In a further study, Davies and colleagues observed the relationship and 
course of disease when lambs were infected with ovine adenovirus followed by 
Pasteurella haemolytica (Ph)." Ten to eleven week old caesarian-derived, 
colostrum-deprived lambs were used in the study. Various groups of lambs were 
given different combinations of virus or bacteria.  Clinically the group which re­
ceived the virus followed by the bacteria developed more severe signs of respirato­
ry tract disease while the groups that received the virus or bacteria alone had minor 
signs.  Similarly, reisolation of bacteria from the group inoculated with Ph alone 17 
was low as compared to the group which received both bacteria and virus together. 
This showed that bacteria alone was eliminated efficiently from lungs by body de­
fense mechanisms. This study suggested that the OAV strain WV 419/75, must be 
considered as another potential respiratory pathogen capable of initiating a bacte­
rial bronchopneumonia." 
Respiratory Syncytial Virus (RSV) 
Berthiaume et al. reported the presence of RS virus complement-fixating an­
tibodies in Quebec (Canada) sheep.  Survey report indicated that 81% sheep se­
rums were positive to RSV, which was higher than bovine (14%) and horses (6%) 
serums.' 
Spraker and Collins reported the presence of BRSV in Colorado bighorn 
sheep. Serum samples from animals showing signs of respiratory distress revealed 
the presence of antibody titres to BRSV and PI-3. Respiratory syncytial virus was 
present in tissues of the respiratory tract of sheep which died of the disease."' 
Dunbar et al. reported the sereoprevalence of RSV infection in free-ranging, 
6 months to 18 years old, bighorn sheep from 9 western states of USA." Survey 
results showed that 42% (187/447) had SN antibodies to BRSV with titers ranging 
between 1:5 and 1:640 (median titre was 1:10). 
Evermann and others' conducted indirect immunofluorescence and virus 
isolation test on sheep showing the signs of rhinitis. They revealed the presence of 
RSV. This isolate was neutralized by BRSV antisera and later was identified as 
ovine RSV. They concluded that RSV can be grouped among the viruses which 
cause mild respiratory problems in sheep. 
Intranasal and intratracheal inoculation' of lambs with an ovine strain of 
RVS resulted in mild clinical  signs of respiratory tract disease and mild 18 
pathological changes in the lung. This virus also caused the lower respiratory tract 
lesions in experimentally infected calves and deer. 
Lehmkuhl and coworkers successfully infected lambs with RSV of bovine 
origin."  Lambs manifested clinical illness, lesions, and serologic titers against 
BRSV. Virus was reisolated from nasal secretions collected 5 day PI and from tra­
cheal fluid and lung tissue on day 7 PI.  In another experiment, Lehmkuhl and 
Cut lip infected 6-months-old (feedlot-aged) lambs with BRSV and found the same 
findings as reported for young lambs." 
Cut lip and Lehmkuhl described the lesions in lambs infected experimentally 
with BRSV. The main pulmonary lesions observed were multifocal areas of con­
solidation with necrosis of individual epithelial cells of airways and accumulation 
of necrotic material in terminal airways." 
Trigo et al. inoculated lambs with BRSV via aerosol route which resulted in 
mild clinical response on day 4 PI. Bovine respiratory syncytial virus was reiso­
lated from nasal secretions samples taken in between 2 to 6 day PI. No outstand­
ing macrolesions were observed. Virus was mainly present in alveolar walls and 
occasionally in bronchiolar epithelium. Low levels of BRSV specific antibodies 
were detected in pulmonary washings.' 
Sharma and Woldehiwet described the experimental infection of BRSV in 
lambs.' Clinical signs of disease were limited to respiratory distress i.e. dysp­
noea, hyperpnoea and cough.  Virus was recovered from nasal swabs in 38% 
(9/24) of infected lambs between 3-7 day PI. Virus was reisolated from tracheal 
and lung tissue of all sheep killed between 3 to 11 day PI. Bovine respiratory syn­
cytial virus antibodies were first detected on day 6 PI with highest titers in be­
tween day 14 to 21 PI. The main pathological findings were multifocal areas of 
consolidation. 19 
Trigo and coworkers studied the interaction125 of BRSV and Ph in respiratory 
tract disease. Mild clinical signs were seen in lambs given virus and/or bacteria. 
Gross respiratory tract lesions were present in 50% (3/6) of lambs which received 
the virus followed by bacteria, 3 or 6 day PI of virus. The lambs which received 
the virus and bacteria simultaneously also had gross lesions but these were less se­
vere than in the previous group (1/6). However, gross lesions were absent in the 
lambs which only received virus or bacteria alone or the group which received the 
bacteria first followed by virus. These results showed that viruses initiate the pro­
cess and bacteria produces the severe symptoms.'25 
Al-Darraji and coworkers' experimentally infected lambs with RSV and Pas­
teurella haemolytica (Ph) and studied the clinical and microbiological response. 
Lambs inoculated with either agent or in combination manifested clinical signs but 
signs were more pronounced in lambs which received virus first and then bacteria. 
It was observed that lambs which received bacteria 5 days PI of virus were af­
fected more severely than those that received bacteria 3 days PI of virus. About 
50% (8/15) samples revealed the presence of virus and all lambs responded sero­
logically to RSV but not to Ph. In a previous experiment,' these researchers dem­
onstrated the viral antigens in bronchial and bronchiolar epithelium and in the 
alveolar walls by using the immunofluorescence technique. No bacterial antigen 
was detected. 20 
Border Disease Virus (BDV) 
The clinical effects of BD virus on fetal lambs were first described by Mark-
son and coworkers in 1959.85 Although the presence of the virus was not con­
firmed in this report, it represent the earliest clinical description. The disease was 
referred to as hypomyelinognesis congenita of sheep. The disease, with unknown 
etiology, was clinically characterized by trembling, ataxia, and shaking of head. 
Detailed examination revealed no gross abnormalities with negative bacteriology 
on brain and spinal cord specimens." 
Hughes et al. described the disease syndrome in newborn lambs and named it 
"B" or border disease. This disease with unknown etiology was clinically charac­
terized by a change in birth coat, smaller lambs with retarded growth and varying 
degrees of trembling." 
Border disease of sheep is of economic importance due to persistence of viral 
infection which results in infertility and abortion, low survival rate, and low car­
cass of affected lambs. Sawyer et al. studied a flock of sheep in which border dis­
ease was enzootic.112 At the start of the study 82% (125/152) ewes were 
seropositive to cross-reacting BVDV. Lambs born to these ewes manifested clini­
cal signs of BD. Virus was recovered from blood lymphocytes and was shed in 
urine, saliva, and feces through 10 weeks of age. 
Niemi et al. described the prevalence of BD virus in Idaho sheep.' It was 
found that 29% (73/249) were seropositive to the antigenically related togavirus, 
BVD virus. For neonatal lambs,51% (172/337) possessed antibodies to BVD vi­
rus.  It was also observed that a significant number of BVDV seropositive lambs 
were derived from seronegative dams. Beside serologic evidence, BD virus was 
isolated from nasal and vaginal samples obtained after 24 hours of parturition. 21 
Ames and coworkers investigated fetuses from a flock of sheep with the 
complaint of hairy fleece, rhythmic tremors, and unthrifty signs in young lambs.' 
Beside detecting a virus antigenically related to BVD virus, high  serum titers of 
antibodies against the virus were present in newly born lambs. This observation 
indicated that in utero infection with border disease can occur in lambs. 
Osburn and coworkers conducted the SN test on serums of lambs naturally or 
experimentally infected with BD virus and estimated immunoglobulin gamma con­
tent (IgG). Results showed that IgG level in precolostral control samples was less 
than 0.10 mg/ml while it ranged in between 0.10 to 1.1 mg/nil in infected lambs. 
Postcolostral values exceeded 7.5 mg/ml. Serum neutralizing antibodies to hog 
cholera were detected in 100% (13/13) of lambs which were infected and the level 
ranged between 1:4 to 1:1024. Sixty two percent of the total samples (8/13) show­
ing antibody levels to hog cholera also had antibodies to BD virus.' It should be 
noted that BD virus and hog cholera share common antigens. 
Potts and coworkers isolated BD virus from the CNS and spleen of an in­
fected lamb.'" The virus was propagated in tissue cultures without apparent CPE. 
Primary sheep choroid plexus cultures were used to develop a vaccine for use in 
adult healthy sheep. It was noted that there was a slow response to production of 
neutralizing antibodies which were detected as late as 43 days PI. 
Harkness and coworkers isolated and propagated BD virus from brain and 
spleen fragments of lambs with the disease.' The virus was used to produce dis­
ease in ewes in their 35th day of gestation. Lambs born to these ewes showed va­
rying degrees of clinical signs of border disease. 
Terpstra detected Border disease antigen in tissues of sheep showing clinical 
signs of disease as well as in cell cultures during virus isolation studies.' The 
study showed that in young animals almost every organ was involved, as demon­
strated by immunofluorescence.  It was also observed that a number of organs 22 
involved decreased with the advancement of age. Antigen was present in cultures 
grown from kidney, brain, and testicles, even in tissues of lambs whose sera was 
negative to neutralizing antibodies.  The author mentioned that immunofluores­
cence in the CNS was usually absent or was limited to scattered neuron bodies in 
the cerebral cortex and cerebellum.  Virus was present in the respiratory tract 
mainly in secretory glands of the submucosa.122 
Anderson and coworkers experimentally produced BD in lambs by inoculat­
ing their dams at 50 days of gestation.' Dams showed the presence of SN antibo­
dies to BVDV while lambs manifested the clinical signs of BD. The virus  was 
readily detected by fluorescent antibody studies in both white and gray matter of 
spinal cord cells of lambs. 
French et al. inoculated pregnant ewes intravenously (IV) with an ovine iso­
late of BVD virus on different days of gestation and necropsied them 15 days after 
the last inoculation." Virus was not recovered from fetuses or fetal membranes of 
ewes inoculated at 14 to 16 day post mating. But virus was present in placentas 
and fetal membranes of sheep in a group inoculated between 36 to 119 days after 
mating. Highest recovery of virus was from the ewes inoculated in 36 to 38 and 
60 day post mating. The researchers observed no macro or microscopic lesions in 
fetuses, placentas or uteri. All ewes, which were given the inocula intravenously, 
showed presence of SN antibodies to virus while 85% (11/13) suckling lambs also 
showed a titer to the virus. The titers were lower in the groups which were fed vi­
rus in food and drinking water than those which received virus intravenously. A 
similar situation was seen with suckling lambs." 23 
Parainfluenza virus-3 (P1-3) 
Hore, D.E reported the isolation of PI-3 virus from sheep in the United King­
dom. Virus was identical to PI-3 virus isolated from cattle when considering the 
morphological, chemical, and serological properties of the virus." 
Lehmkuhl and Cutlip isolated and characterized the PI-3 virus from  a lamb 
which died during the course of an enzootic of acute respiratory tract disease." 
Ditchfield reported the presence of PI-3 virus in Canadian sheep and found 
the same properties of the virus as described by Hore in 1966.' 
Bluetongue Virus (BTV) 
Erasmus described the importance, clinical manifestation, and economic sig­
nificance of bluetongue in South African sheep and goats. Bluetongue is basically 
a disease of sheep and almost all breeds whether indigenous or non-indigenous are 
susceptible to this virus to varying degrees." Clinical signs starts with high tem­
perature which may fluctuate markedly. Hyperpnea and hyperemia of buccal and 
nasal mucosa can be observed which may result in salivation and frothing at the 
mouth. Economically, direct losses occur due to mortality but indirect losses i.e. 
delayed marketing, weight loss, poor body condition, and low carcass scores, are 
of greater economic importance. 
Odiawa et al. conducted a serosurvey for bluetongue (BT) and epizootic 
hemorrhagic disease (EHDV) in ruminants in Georgia.' Beside cattle, deer, and 
goats, 34% (97/286) of sheep were seropositive to BT virus while 29% (83/286) 
had antibodies to EHDV. The virus was isolated from healthy sheep  as well as 
those showing signs of disease. 24 
Seroepidemiological Surveys (OAV, RSV, BDV, P1-3, BTV) 
Lea Master and coworkers conducted a serologic prevalence study in a flock 
of sheep in Idaho to determine the presence of neutralizing antibodies against bo­
vine viral diarrhea/border disease (BVD/BD), parainfluenza type 3 (PI-3), infec­
tious bovine rhinotrachitis (IBR) and respiratory syncytial virus (RSV).  The 
highest percentage of antibodies was found in neonates which appeared to be of 
colostral origin. As the antibody titre decreased in young lambs, natural infection 
occurred and the prevalence of antibodies increased. Adult sheep had detectable 
antibody titers against all viruses except IBR. Serosurvey results from adult sheep 
showed the prevalence of antibodies for PI-3 to be 88% (65/74), for BVD/BD 39% 
(29/74) and for RSV 57% (42/74).73 
Lelunlcuhl and others conducted a two year seroepidemiological study77 on 
lambs for the presence of common respiratory viruses. First serum samples were 
collected from 1-2 month old ram lambs and the second samples were taken two 
months later.  Serum virus neutralization test, HI and AGD tests, appropriate to 
each virus, were used to determine the presence of antibodies. The  mean preva­
lence for both years of blood collection shows; 95% for OAV-5, 87.2% for PI-3 
virus, 84.5% for RSV, 41.7% for OAV-6, 8.7% for BVD virus, 5.4% for BHV-1 
and 3.3% for ovine progressive pneumonia (OPP) virus.  Ovine adenovirus-6 
(RTS-42) had the highest infection rate on the basis of mean of two year serum 
analysis i.e. 42.8% (207/484) as determined by the increase of greater than 4-fold 
serum antibody titre from the first to sceond sample. Infection rates for other vi­
ruses were; 31.1% for OAV-5 (RTS-151), 15.3% PI-3 virus, 5.6% for RSV, 0.6% 
for BVD virus and 0.4% for BHV-1. 
A seroprevalence survey for antibodies to seven viruses  was conducted in 
Minnesota (USA) with healthy ewes. Three different tests, specific to each virus, 
were used in order to determine the level of antibodies.  The result showed 25 
presence of antibody of 0.3% for BVDV (1/377), 0.5% (2/377) for IBR, 7.6% 
(29/378) for BAV-3, 52.5% (200/378) to BRSV, 71.7% (273/273) for PI-3 virus, 
and 55% (210/379) for ovine progressive pneumonia (OPP).  Serums of all 
sampled ewes were negative to blue tongue virus (BTV) antibodies. Presence of 
antibodies to adenoviruses were not included in the study." 
A seroprevalence survey against some viruses in Louisiana sheep was carried 
out by Brako and coworkers. There was a prevalence of 2.5% (4/158) for BVDV, 
74.1% (117/158) for PI-3 virus, 48.7% for BRSV, and 13.3% (21/158) for BTV. 
Sera from all sheep was negative to BHV-1 and BLV (bovine leukemia virus).25 
In a survey conducted in Canada by Elazhary et al. it was found that antibo­
dies against the four common respiratory disease-producing viruses were present 
in the serums of healthy sheep and goats. It was reported that antibodies to BRSV 
were present in 31%, BVDV 22.2%, bovine herpesvirus-1 10.8%, and for PI-3 
23.2%." No age differences among adult and young animals were found in re­
sponse to antibody prevalence. 
A seroprevalence survey62 against some respiratory virus in sheep and goats, 
in Quebec (Canada) showed that 28%, 72% and 35% of sheep and 26%, 64% and 
36% of goats were seropositive to PI-3 virus, reovirus type 3 and RSV, 
respectively. 
Adair and colleagues conducted a serosurve? for antibodies to respiratory 
viruses in Northern Ireland. They compared non indigenous breeds of sheep to 
indigenous breeds in order to determine the differences in prevalence of serum an­
tibodies against most commonly involved viruses causing respiratory problems. It 
was estimated that 56% (112/200) of non indigenous sheep had antibodies to PI-3 
in contrast to 50% (100/200) for indigenous breeds. A marked difference was 
noted in the incidence of antibodies to BDV with non local sheep possessing anti­
body in 53% (106/200) of cases while local sheep showed 11% (22/200) 26 
prevalence. As cited earlier, adenovirus infection is common in sheep all over the 
world, 89.5% (179/200) non Ireland sheep had antibodies to OAV-1 whereas 83% 
(163/200) Ireland sheep were seropositive to the same virus.  The antibodies 
against OAV-2 were present in 81.5% (163/200) of non indigenous sheep while 
69% (138/200) indigenous sheep had antibodies to same virus. 
A pathological and microbiological survey on respiratory disease in lambs 
was carried out in Northern Ireland. The study lasted for two years and involved 
lambs 14 to 16 weeks of age. Beside bacteria, samples also showed the presence 
of neutralizing antibodies to RSV and PI-3 virus.  Sera was negative to PI-3 on 
entry to the fattening facility but, after 3 weeks almost all animals showed antibo­
dies to PI-3 virus.  First year survey indicated no antibodies to RSV during a 9 
week survey period. Second year serum analysis revealed the presence of antibo­
dies to PI-3 virus at higher levels i.e. 99% (79/80) and to RSV 20% (16/80)." 
These researchers did not examine serum for evidence of antibodies to ovine 
adenoviruses. 
Davies and coworkers conducted a longitudinal serologic study' by collect­
ing monthly serum samples from four flocks of sheep of different ages in New 
Zealand. Serums were tested against two known viruses i.e. PI-3 and adenovirus 
(AV) WV 757/75. Both viruses were isolated from the sheep in New Zealand. 
Maternal antibodies were present in new born lambs against both viruses but they 
declined until all lambs were susceptible to both viral infections. All the new in­
fections, as indicated by rising antibody titers, showed the presence of both viral 
infections to lambs. These investigators suggested the possible role of these vi­
ruses in causing pneumonia in sheep, although no casual relationship could be 
proven. 
Rosadio et al. conducted a seroepidemiological survey in Peruvian sheep. 
Samples were collected from different regions of the country to determine 27 
antibody levels and thus evidence of previous viral infection.  Immunoassay for 
seven different viruses by specific test to each virus indicated that 47% (16/34) of 
sheep were positive to RSV, 82% (28/34) for PI-3 virus, 3% (1/34) for BVD/BD 
virus, 56% (19/34) for blue tongue virus (BTV), and 15% (5/34) for ovine progres­
sive pneumonia (OPP) virus. No antibodies were detected to BHV-1 and bovine 
leukosis (BLV) virus." 
Loken et al. conducted a serological investigation' in ruminants in Norway. 
Beside other ruminants, a total of 3712 ewes (103 flocks) serums were tested for 
antibodies to BVD virus. The prevalence rate of seropositive ewes were 4.5% and 
seroreactors were found in 18% of sheep flocks. The research group noted a high­
er titre of antibody against the bovine virus than against the antigenically related 
swine fever virus. 
Pommer and Schamber conducted a two year study on recently weaned 
lambs to determine the dynamics of antibody titre increase to PI-3 virus, RSV, and 
an untyped OAV. Virus isolation study for two years showed that PI-3 virus was 
present in 1/275 while OAV was present in 13/275.  Adenovirus antibody titers 
varied greatly with age of the animal and stage of infection.  During the period 
from weaning to when samples were taken at the acute phase of infection, 11.7% 
(14/119) had a four fold increase in serum antibody. From acute to convalescent 
disease period, 5.8% (7/119) showed a four-fold increase in antibody titre. Very 
little change was observed in PI-3 virus antibody titer range in lambs showing 
signs of disease during the two-years of study.  Only 2.5% (3/118) lamb had a 
four-fold increase in antibody titers from the acute phase of disease.  No appre­
ciable change was seen in RSV antibody titers during the study. These conditions 
showing that RSV was not involved in causing respiratory problems.' 
In order to determine the cause of abortion in cattle and ewes, Kirkbride and 
coworkers tested the serum of 994 bovine and 553 ovine aborted fetuses against 28 
border disease (BD) virus, bluetongue (BT), bovine viral diarrhea (BVDV) virus, 
and leptospiral infection." No antibodies were found against BT from aborted 
bovine and ovine fetuses. Bovine viral diarrhea virus was detected serologically in 
3 of 80 aborted fetuses from ewes. While BD virus was detected in 14 of 486 fetal 
lambs, only 3 of 12 serums tested showed antibodies to BD virus. Study showed 
that these viral agents do infect the fetuses but it is very difficult to determine 
when they are the cause of abortion. Previously it had been demonstrated that bo­
vine fetuses are capable of responding immunologically to these agents at some 
stage of pregnancy. 29 
III. MATERIALS AND METHODS 
Test Animals 
This investigation was conducted during June and July, 1991 and involved 
three different studies. Two studies were conducted in a feedlot near Hermiston, 
Oregon and the third was conducted in a feedlot near Platteville, Colorado. Lambs 
in the Oregon studies were purchased from multiple sources in the Willamette 
Valley of Oregon, while lambs in the Colorado study  were purchased at various 
locations in the state of Texas. In all cases, lambs were of mixed breeds and var­
ied in weight from 27 to 36 Kg. 
The first Oregon study was composed of 200 subjects which were chosen at 
random from approximately 800 lambs within two days of their arrival at the feed­
lot.  The feedlot was feeding approximately 5000 lambs at the time. The study 
lambs were placed in pens by themselves, a permanent tag was affixed to their 
ears, and a blood sample for serological studies was taken. A second blood sample 
was taken from the same animals 21 days later. Lambs which died from respirato­
ry tract disease were necropsied at the feedlot. Intact lungs and associated lymph 
nodes were removed and preserved with containers of frozen water and shipped to 
the laboratory. On arrival, samples of lungs and bronchial and mediastinal lymph 
nodes were removed, sections were made with a cryostat, and, the sections were 
examined by fluorescent microscopy for viral antigens.  Serums were separated 
from rbcs at a local laboratory, frozen at -20C and shipped to the laboratory at the 
end of the trial in a frozen state. 
The second Oregon study was a seroprevalence investigation for antibodies 
to the viruses in question. Fifty lambs which entered the feedlot from 6-15-91 to 
6-18-91 were selected at random from five different pens (N=250) and blood sam­
ples for serological studies were taken. The number of lambs per pen varied from 30 
500 to 700. A second blood sample for serological studies was taken from animals 
which were selected at random from the same pens 24 days later, i.e., blood  sam­
ples were not paired. Serum was separated from rbcs, frozen at -20C and shipped 
to the laboratory while frozen. 
The Colorado study was initiated on 6-3-91 and was identical to the first 
Oregon study and involved 200 subjects. Lambs which died of respiratory tract 
disease were not necropsied and samples were not examined for viral antigen. 
Paired serum samples from surviving lambs were separated from rbcs, frozen at 
-20C and shipped to the laboratory at the end of the trial. 
Mediums 
Mediums for growth and maintenance of cell cultures and for dilution of vi­
ruses was minimal essential medium in Ear les balanced salt solution (MEM).3 
Growth and maintenance mediums contained 100 units of penicillin and 100 lig of 
streptomycin sulfate per ml. Growth medium was supplemented with ten percent 
fetal bovine serum and maintenance medium was supplemented with five percent 
fetal bovine serum. 
Cell Cultures 
Bovine turbinate cells" (BT) and ovine fetal turbinate cells' (OFTU)  were 
propagated in plastic flasksd and transferred to provide additional stock cultures or 
used in multi-well plastic plates for virus neutralization (VN) tests. 
Source of Viruses 
Bovine viral diarrhea virus (BVDV),e respiratory syncytial virus (RSV),f 
ovine adenovirus (OAV-6),g and parainfluenza-3 (PI-3)," (Ressinger strain),  were 
received from different sources. Bovine viral diarrhea virus, and P1-3 virus were 31 
propagated in BT cells while OAV-6 was propagated in OFTU cells. Respiratory 
syncytial virus was propagated in African green monkey kidney cells (Vero cells). 
Assay for Antibodies 
Presence of VN antibodies to BVDV (border disease virus, BD), RSV and 
OAV-6 were assayed in microtiter plates.' Serums were heat-inactivated at 56C 
for 30 minutes and diluted in 2-fold steps using an initial serum dilution of 1:4. 
An equal volume of virus (50 Lt1) which contained 100 tissue culture medium in­
fectious doses (TCID50) was added to each serum dilution. The mixture was incu­
bated 1 hour at 25C at which time 50 µl of growth medium containing 5x105 cells 
was added. One drop of sterile mineral oil was placed in each well and the plates 
were incubated at 37C in an atmosphere of 2.5 percent CO2. Cultures were ex­
amined for cytopathogenic effect (CPE) 5 to 7 days later. Each serum was tested 
in duplicate and serum end point titers were tabulated as the last (most concen­
trated) dilution in the series which inhibited CPE in both dilution sets of serum. 
Serums were considered to possess SN antibodies to virus if it inhibited CPE at 1:4 
dilution. With paired serums, an animal was considered to have undergone serum 
conversion to a virus if it produced a 4-fold or greater antibody increase when 
comparing the first and second serum samples from the same animal. 
Antibodies to PI-3 virus were tested by the hemagglutination-inhibition (HI) 
test. Serum was treated with a 25% suspension of acid-washed Kaolin. Serums 
were diluted in 2-fold steps in round bottom microtiter plate& beginning with a 
1:4 dilution. An equal amount of virus (54.1) containing 8 hemagglutination units 
was added. After one hour incubation at 24C, 50 gl of a 0.2 percent suspension of 
washed bovine red blood cells (rbc) were added to each well. The plates were in­
cubated 2 hours at 24C and examined for hemagglutination. A serum was consid­
ered to possess HI antibodies if it inhibited agglutination of rbc at a 1:8 dilution. 32 
As with the SN test, definition of serum conversion required a 4-fold or greater an­
tibody titer increase with paired samples. 
Agar gel test immunodiffusion kits were used to measure antibodies to ovine 
progressive pneumonia (OPP).'` Any evidence of a precipitation line in the agar 
with the test serum which joined to the positive control serum line constituted the 
evidence of antibodies to OPP. 
The agar gel immunodiffusion (AGID) test was used to detect antibodies to 
bluetongue virus. Antigen and positive control serum were purchased from a com­
mercial laboratory and the test was conducted following the vendor's directions.' 
Fluorescent Antibody Technique (FAT) 
Conjugated antiserum used to detect viral antigen to BVDV, RSV, and PI-3 
were received from the OSU Veterinary Diagnostic Laboratory."' Antiserum to 
OAV-6 was prepared specially for this project.  Culture flasks containing OFTU 
cells were inoculated with the virus and, after cell cultures developed a cytopathic 
effect, they were scraped from the flasks and resuspended in a saline solution. The 
cells were subjected to ultrasonic disruption and the preparation was clarified by 
centrifugation at 3000 times gravity for 20 minutes. The clarified virus suspension 
was subjected to isopycnic centrifugation (density 1.33 g per ml ) at 100,000 times 
gravity for 36 hours at 4C. The adenovirus band was dialyzed against physiolog­
ical buffered saline (pH 7.5) for 12 hours. The preparation was divided into four 
aliquots. Aliquot one was mixed with an equal volume of Freund's Complete Adju­
vant and injected subcutaneously and intramuscularly in a New Zealand white rab­
bit. Aliquots 2-4 were frozen until they were used at which time they were thawed 
and mixed with an equal volume of Freund's Incomplete Adjuvant. One aliquot 
each was injected into the original rabbit on day 7, 14, and 21 by subcutaneous in­
oculation. The rabbit was exsanguinated by cardiac puncture on day 35. Serum 33 
was separated from red blood cells and stored at -20C until it was used as positive 
control for SN test or to conjugate for fluorescent antibody studies. 
Preparation of serum and method of conjugation with fluorescence isothio­
cyanate (FITC), was followed as a routine laboratory procedure.' Sections were 
reviewed with a Zeiss compound microscope using epifluorescence. Filtration of 
light was designed specifically for use with FITC.  Sections of lung, bronchial and 
mediastinal lymph nodes were prepared with a cryostat and placed on a glass slide. 
The tissue was dried at 37C, then fixed in a 100 percent acetone solution for 20 
min. After fixation, the tissue was again dried at 37C for 20 minutes. A few drops 
of conjugated antiserum (a different slide contained tissue for each conjugate) was 
placed on each tissue section. The preparations were incubated in a humidified 
chamber at 37C for 20 minutes after which it was rinsed with fluorescent antibody 
buffer (physiologic saline, M/15 phosphate buffer pH 7.6). The slide was rinsed 
in distilled water for 20 seconds, dried to remove water, and mounted in FA 
mounting solution with a coverslip.  Positive control tissue (to check each conju­
gate) was routinely prepared. Detection of viral antigen was apparent by the ap­
pearance of focal areas of intracellular fluorescence. 
Statistical Analysis 
Statistical analysis was employed in the seroprevalence section of this inves­
tigation (Second Oregon Study). The significance of prevalence of antibodies to 
the tested viruses was evaluated by the Chi Square test. 34 
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IV. RESULTS
Fluorescent antibody examination of the 40 sheep which died of respiratory tract 
disease during the first Oregon study is presented (Table 1, Figure 1).  Presence of RSV 
antigen in one or more of the tissues of the respiratory tract was highest, with 9/40 cases 
(22.5%), being positive. This was followed by PI-3 in 6/40 cases (15%); antigen of BDV 
or OAV-6 alone was not present in any case. Mixed infection involving different combi­
nations of viruses was found in eight cases. Results showed that RSV-BDV- OAV-6 was 
present in 2 of these 8 samples each while a combination of RSV-OAV-6 was detected in 
3 of these 8 cases. A combination of BDV-PI-3, OAV-6-PI-3 and RSV-PI-3 was present 
in 1 of these 8 cases each. The combination of BDV-OAV-6 was not detected. No virus 
was detected in 17 of 40 cases. 
When tabulating the presence of virus either alone or in combination with other vi­
ruses, RSV was detected most commonly in 15 of 40 cases (37.5%). This was followed 
by PI-3 in 9 of 40 cases (23%), OAV-6 in 6 of 40 cases (15%) and BDV in 3 of 40 cases 
(7.5%). 
Fluorescent antibody examination of individual tissue of the respiratory tract (lung, 
bronchial and mediastinal lymph nodes) and the presence of viral antigen detected in such 
tissue is presented (Table 2). Autolytic changes occasionally made the examination of all 
tissues difficult or impossible.  This was particularly true with the mediastinal lymph 
node when autolytic changes appeared to be more extensive. 
The cumulative total of lambs that died of respiratory tract disease during the first 
21 days of feeding is presented (Table 3). Of the 47 deaths, 23 deaths (49%) occurred 
during the first four days of feeding. When viral antigen was detected during this 4-day 
period (12 cases) the viral antigen was RSV in 7 of the 12 cases (58 %, data not shown). 36 
Serum samples taken from lambs when they entered the feedlot in the first Oregon 
study showed they varied greatly with their previous exposure to the virus in question 
(Table 4).  Presence of antibodies to RSV was most common and found in 86 of 200 
cases (43%). This was followed by OAV-6 in 65 of 200 cases (33%), P1-3 in 36 of 200 
cases (18%), BTV in 13 of 200 cases (7%) and BDV in 8 of 200 cases (4%) (Table 4 and 
Fig 2). 
Seroconversion during the first 21 days with the different viruses also varied great­
ly.  Seroconversion was highest with P1-3 in 72 of 153 cases (47%) followed by RSV in 
53 of 153 cases (35%), OAV-6 in 24 of 153 cases (16%), BDV in 7 of 153 cases (5%) 
and BTV in 3 of 153 cases (2%) (Table 4 and Figure 2). 
The seroprevalence study (second Oregon study) showed some variation with the 
prevalence of antibodies as presented in the first Oregon study. Serum taken on entry to 
the feedlot showed that no lambs possessed antibodies to P1-3 virus. However, there was 
a varying degree of antibodies to the other viruses (Table 5 and Figure 3). Lambs enter­
ing the feedlot possessed antibodies most commonly to OAV-6 when they were found in 
122 of 255 cases (48%). This was followed by RSV in 93 of 255 cases (36%), and BDV 
in 6 of 255 (2%). Prevalence of antibodies 24 days later showed a higher prevalence to 
all viruses (Table 5 and Figure 3). Antibodies to RSV was highest in 220 of 250 cases 
(88%) followed by OAV-6 in 215 of 250 cases (86%), P1-3 in 18 of 250 cases (7%) and 
BDV in 17 of 250 cases (7%). There was a significant increase in all cases in the number 
of lambs possessing antibodies at day 28 as compared to those which possessed antibo­
dies on entry into the feedlot (13?..01). 
Lambs possessed antibodies to all the test viruses on entry into the Colorado feedlot 
(Table 6, Figure 4). Antibody to RSV was highest and found in 49 of 200 cases (25%). 
This was followed by OAV-6 in 32 of 200 cases (16%), P1-3 in 22 of 200 cases (11%) 
BTV in 4 of 200 cases (2%) and BDV 1 of 200 cases (0.5%). Lambs underwent infection 
with all viruses during the succeeding 21 days as evidenced by seroconversion (Table 6 37 
and Figure 4). Infection with PI-3 was highest with 93 of 181 cases (51%) this was fol­
lowed by OAV-6 in 34 of 181 cases (19%), RSV in 30 of 181 cases (17%), BTV in 3 of 
181 cases (2%), and BDV in 2 of 181 cases (1%). 
Isolation of bacteria and detection of mycoplasma was only undertaken from respi­
ratory tract samples from lambs in the first Oregon study (Table 7). Cultures from lambs 
with extensive autolysis when necropsied were not included in the study.  Pasteurella 
hemolytica was isolated most frequently, both in lambs where no virus was detected as 
well as lambs where one or more of the four viruses being studied were observed by fluo­
rescent microscopy examination (53% and 52% of cases). Other bacteria and mycoplas­
ma species were detected from respiratory tract samples (Table 7). Due to the low 
number of animals where the different bacteria species were detected, data was not sub­
jected to statistical analysis. 38 
Table 1: Detection of viral antigen in respiratory tract tissues in lambs that died 
of respiratory disease (first Oregon study). 
Virus(es) 
(A)  RSV 
(B)  P1-3 
(C)  BDV 
(D)  OAV-6 
(E)  RSV-BDV-OAV-6 
(F)  BDV-PI-3 
(G)  RSV-OAV-6 
(H)  RSV-PI-3 
(I)  OAV-6-PI-3 
(J)  No virus detected 
Number  Percent 
9/40  22.5 
6/40  15 
None  0 
None  0 
2/40  5 
1/40  2.5 
3/40  7.5 
1/40  2.5 
1/40  2.5 









(A)  (B)  (C)  (D)  (E)  (F)  (G)  (H)  (I)  (J) 
Figure 1: Percentage of positive antigen detected in the first Oregon study 
(see also Table 1). 
(A) RSV, (B) PI-3, (C) BDV, (D) OAV-6, (E) RSV-BDV-OAV-6, 
(F) BDV-PI-3, (G) RSV-OAV-6, (H) RSV-PI-3, (I) OAV-6-PI-3, 
(J) No virus detected . 40 
Table 2: Fluorescent antibody examination of respiratory tract tissues of sheep 
that died in first Oregon study. 
Positive tissues  BDV  P1-3  BRSV  OAV-6 
Lung  3/40  7/40  8/40  5/40 
Percentage  8.00%  18.00%  20.00%  13.00% 
Bronchial lymph  2/38  7/38  9/36  4/38 
node 
Percentage  5.00%  19.00%  25.00%  11.00% 
Mediastinal  0/35  3/35  11/35  3/35 
lymph node 
Percentage  0.00%  8.50%  31.00%  9.00% 41 
Table 3: Cumulative death of lambs which died of respiratory tract disease 
during the first 21 days of feeding (First Oregon Study). 
Day of cumula- Autolysis; not  Viral antigen  Viral antigen not Total cumulative 
tive feeding  tested for viral  detected  detected  deaths 
antigen 
1 0 5 8  13 
2  1 3  1 18 
3  1 2 0 21 
4  0  2 0 23 
5  0 0  1 24 
6 0 0  1 25 
7 0 1  1 27 
9  0  1 0 28 
11 0 2  1 31 
13 0  1  1 33 
16 0  0  1 34 
17 0  0  1 35 
18 0  0  1 36 
24  1 0 0 37 
25 0  0  1 38 
26 0  1 0 39 
27 0  1  0 40 
28  1 0  0 41 
32  1 0  0 42 
38  0  1 0 43 
39  1 0  0 44 
42 0  1 0  45 
44 0  1 0  46 
61 0  1 0 47 
Total  6  23  18  47 42 
Table 4: Serological response of lambs to selected viruses in first Oregon study, 
first 21 days in feedlot. 
BDV  PI-3  RSV  OAV-6  BTV Specimen 
Number with  detectable 8/200  36/200  86/200  65/200  13/200 
antibody on entry 
Percentage  4.00%  18.00%  43.00%  33.00%  13.00% 
Number with serocon- 7/153  72/153  53/153  24/153  3/153 
veiled (  4-fold titer 
increase) 
Percentage  5.00%  47.00%  35.00%  16.00%  2.00% 43 
50  Percentage with antibody 
on entry 
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Figure 2: Percentage of serological response of lambs to selected viruses in 
first Oregon study, the first 21 day in feedlot (see also Table 4). 44 
Table 5: Seroprevalence of antibodies to selected viruses in an Oregon feedlot. 
Samples were taken from 10 percent lambs in five pens on entry and 
after 24 days (Second Oregon Study). 
Specimen BDV  P1-3  RSV  OAV-6 
Number with detectable antibody on entry 
6/255  0/255  93/255  122/255 
Percentage  2.00%  0.00%  36.00%  48.00% 
Number with detectable antibodies at 24 
17/250 18/250  220/250  215/250
days 
Percentage  7.00%  7.00%  88.00%  86.00% 45 
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Figure 3: Percentage of seroprevalence of antibodies to selected viruses in 
an Oregon feedlot.  Samples were taken from 10 percent of 
lambs in five pens on entry and after 24 days (the second 
Oregon study) (see also Table 5). 46 
Table 6: Serological response of lambs to selected viruses in a Colorado 
feedlot, first 21 days. 
BDV P1-3  RSV  OAV-6  BTV 
Number with detectable  1/200  22/200  49/200  32/200  4/200 
antibody on entry 
Percentage  0.50%  11.00%  25.00%  16.00%  2.00% 
Number with detectable  2/181  93/181  30/181  34/181  3/181 
antibodies at 24 days 
Percentage  1.00%  51.00%  17.00%  19.00%  2.00% 47 
Figure 4: Percentage of serological response of lambs to selected viruses in a 
Colorado feedlot, first 21 day (see also Table 6). 48 
Table 7:  Detection of bacteria and mycoplasma from lambs in the first 
Oregon study. Data is not included from tissues where autolysis 
was apparent. 
Type of bacteria  No virus  RSV  PI-3  Mixed  All 
detected  viruses  viruses 
P. hemolytica  9/17  7/9  3/6  2/8  12/23 
Percentage  53.00%  78.00%  50.00%  25.00%  52.00% 
P. multocida  4/17  0/9  2/6  1/8  3/23 
Percentage  24.00%  0.00%  33.00%  13.00%  13.00% 
A. pyogenes  3/17  1/9  1/6  0/8  2/23 
Percentage  18.00%  11.00%  17.00%  0.00%  9.00% 
Mycoplasma sp.  6/17  4/9  3/6  3/8  10/23 
Percentage  35.00%  44.00%  50.00%  38.00%  43.00% 
E. colt  1/17  1/9  0/6  1/8  2/23 
Percentage  6.00%  11.00%  0.00%  13.00%  9.00% 
Staph. sp  0/17  1/9  1/6  0/8  2/23 
Percentage  0.00%  11.00%  17.00%  0.00%  9.00% 
Misc. bacteria  4/17  1/9  2/6  2/8  5/23 
Percentage  24.00%  11.00%  33.00%  25.00%  22.00% 
No bacteria isolated  0/17  0/9  0/6  1/8  1/23 
Percentage  0.00%  0.00%  0.00%  13.00%  4.00% 49 
V. DISCUSSION
This investigation was planned for the early summer months when lamb born 
during the preceding spring were scheduled to enter the feeding facility. In both 
the Oregon and Colorado feedlots, respiratory tract disease (RTD) traditionally 
had been a severe problem during the months of June and July. 
Factors which influence RTD are multiple and believed to involve a complex 
interaction between infection with virus, bacteria and mycoplasma species, plus 
environmental factors and stress."' 107 The viruses under consideration in the cur­
rent study are not the only ones implicated as etiologic agents for this disease 
problem but are considered by many investigators as the most important initiators 
of the disease.
60, 68, 73, 78, 79, 105 
Data from the first Oregon study showed the important association between 
infection and stress in initiating RTD as 49% of deaths took place during the first 
four days of feeding. The data from FA examination showed that, of the 12 cases 
where viral antigen was detected during this 4-day period, 7 of the 12 cases were 
positive for RSV. Infection with RSV continued over the entire feeding period as 
the virus spread to additional susceptible lambs. However, death rate was marked­
ly lower after the initial period of stress. At the end of the study , a total of 15 of 
40 lambs (38%) were necropsied and RSV antigen was detected in tissue of the re­
spiratory tract. 
Serologic studies confirmed the importance and prevalence of RSV infection. 
Serologic conversion to RSV in lambs surviving RTD (first Oregon study) was 
evident in 53 of 153 lambs (35%).  Serologic prevalence of antibodies to RSV 
(second Oregon study) indicated that other lambs entering the feedlot at this time 
also were undergoing infection with this virus. Results showed a change from 36 50 
percent to 88 percent prevalence of antibodies to RSV during the first 24 days of 
feeding. 
While not as profound as the two Oregon studies, the Colorado study demon­
strated that RSV infection was common in lambs.  Thirty of 181 lambs (17%) 
which survived RTD seroconverted to the virus during the first 21 days of feeding. 
In addition to the relatively frequent infection rate with RSV, PI-3 virus was 
detected either alone or in combination with other viruses in 9 of 40 lambs (23%) 
that died of RTD (First Oregon study). Serologic studies of surviving lambs con­
firmed a relatively high infection rate of lambs with 72 of 153 lambs (47%) sero­
converting to PI-3 virus.  However, other lambs entering the feedlot at this time 
(seroprevalence study, second Oregon study), did not experience a high rate of in­
fection. None of the lambs entering the feedlot possessed antibodies to PI-3. Af­
ter 24 day of feeding 18 of 250 lambs (7%) had detectable antibodies to this 
virus. To be contrasted with this, 93 of 181 surviving lambs (51%) in the Colora­
do study seroconverted to PI-3. 
Infection with PI-3 in lambs may be sporadic and not predictable in regard to 
rate of infection. Lehmkuhl et al, conducted a serologic survey for antibodies to 
selected viruses involved in RTD of lambs in a ram testing station in Iowa.' Ram 
lambs (1 to 2 months old) were sampled as they entered the feeding establishment 
and a second sample was taken 60 days later.  Infection rate of lambs was deter­
mined by seroconversion. During the first year of the study no lambs (N=236) be­
came infected with PI-3.  However, a thirty percent seroconversion rate to the 
virus (N=248) took place during the second year of study. 
As with RSV and PI-3, Ovine adenovirus has been associated with respirato­
ry tract disease in sheep. The OAV-6 virus was isolated originally from the lungs 
of lamb with pneumonia.'  In the current study, OAV-6 antigen was detected by 
FA in 6 of 40 (15%) lambs that died of RTD. From the same groups of lambs that 51 
survived, 24 of 154 lambs (16%) seroconverted to the virus during their first 21 
days in the feedlot. 
Seroprevalence of antibodies to OAV-6 from representative lots of lambs in 
the feedlot at the same time (second Oregon study) also indicate that infection with 
this virus was common. While paired samples were not taken, 48 % of lambs 
(N=255) possessed antibodies at the beginning of the study. This was significantly 
lower than the 86% prevalence of antibody levels in lambs (N=250) at the end of 
the 24 day feeding period (13.01). Lambs in the Colorado feedlot also showed se­
rologic evidence of infection with OAV-6 with 34 of 181 (19%) seroconverting to 
the virus during the first 21 days. 
Rate of infection with OAV-6 in the current investigation agrees with the re­
sults of a study conducted by Lehmkuhl and coworkers regarding incidence of in­
fection with the virus in young lambs. In a seroprevalence trial of lambs at a ram 
testing station cited previously," serum samples were taken from lambs (ages 1 to 
2 months) as they entered the station and again 60 days later.  Seroconversion to 
OAV-6 in the first year study was 51% (N=234) while rate of seroconversion dur­
ing the second year was 35 % (N=250). Further studies by several investigators 
have shown that OAV-6 alone produces minimal pathogenic changes when in­
jected in specific pathogen-free lambs.  Disease and pathological changes were 
much more severe when lambs were infected with OAV-6 followed in 2-4 days by 
Pasteurella 
There was a special interest in the current study concerning rate of infection 
with BDV. A closely related virus, both in antigenic structure and pathogenesis of 
infection, is bovine viral diarrhea virus (BVDV)." Bovine viral diarrhea virus is 
immunosuppressive and replicates extensively in lymphocytes, macrophage and 
blood platelets. In addition, BVDV replicates in mucus membrane cells of respira­
tory and intestinal tracts.' Most infections occur while young calves and lambs 52 
still retain some colostral antibodies against the virus and an infection is usually 
mild. However, during periods of stress and appropriate infection with other vi­
ruses and bacteria, infection may be severe.12.1" In the current study, BDV anti­
gen was detected by FA in 3 of 40 lambs (8%) in the first Oregon study. 
Likewise, paired serum samples of lambs which survived RTD in the same pen 
showed that only 5% seroconverted to the virus.  Seroprevalence of antibodies 
from lambs in other pens in the feedlot at the same time showed a change of preva­
lence from 2% (N=255) to 7% (N=250) after 24 days in the feedlot. The study in 
a Colorado feedlot again confirmed the relatively low rate of infection with this vi­
rus with a 1% seroconversion during the first 21 days of feeding. 
Results concerning the rate of infection with BDV is consistent also with the 
previous study by Lelunlcuhl et al. where performance of 1 to 2 months old lambs 
were studied in a ram testing station.' After 60 days in the feeding trial, serocon­
version to BDV was 0.4% the first year (N=234) and 0.8% (N=250) the second 
year. While these two investigations i. e, Lehmukuhl et al. and the current inves­
tigation are limited in scope, they are the only significant studies to date conducted 
with BDV in growing feeder lambs in the USA. Until further trials prove other­
wise, it is felt that BDV may not play an important role in respiratory diseases of 
the young feeder lamb. 
Ovine progressive pneumonia is a difficult disease to study using the meth­
ods in the current investigation. The virus induces chronic and progressive lung 
changes and predisposes sheep to other respiratory pathogens.  Seroconversion 
(presence of antibody where previously antibody was not present) follows infec­
tion by 1 to 3 months.' It is very difficult to isolate the virus and traditionally in­
fection is confirmed by the detection of antibody." Assay for antibodies to OPP 
was tested only in lambs in the first Oregon study and no antibodies to the virus 
were detected.  These results were expected as infection with resultant lung 53 
changes and presence of antibody is usually observed in sheep over two years of 
age." 
Infection with BTV does not lead to respiratory tract disease but to a gen­
eralized inflammatory response due to the fact that virus replicates in endothelial 
cells of the vascular system." Infection with BVT predisposes to stress and death. 
The presence of infection was studied to determine if the virus was influencing 
rate of mortality. The virus is difficult to detect and infection is more efficiently 
determined by the presence of antibody using the agar gel immunodiffusion test.' 
Infection rate is quite variable and is influenced by complex factors such as herd 
immunity, presence of infected carrier animals in the area and presence of a high 
concentration of the vector Culicoides veripennis.24 Once sheep are infected, anti­
bodies, as determined by AGID test, may take up to three weeks to reach detect­
able levels.' Seroconversion to BT virus in the first Oregon study indicated 2% of 
lambs developed antibodies to the virus during the first 21 days of feeding. The 
Colorado study likewise showed a 2% seroconversion rate to the virus. However, 
antibodies were present in Oregon lambs (7%) and Colorado lambs (22%) when 
they entered the feedlot. Lambs may have been infected prior to entering the lot 
and they seroconverted during the 21-day test period. Since active infection may 
have taken place up to three weeks previously and seroconversion was relatively 
low, it is felt that active BT virus infection probably did not predispose animals to 
the high mortality rate observed in this study. 54 
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